Invention Grant
- Patent Title: Chimeric inhibitor molecules of complement activation
-
Application No.: US17818583Application Date: 2022-08-09
-
Publication No.: US11945848B2Publication Date: 2024-04-02
- Inventor: Peter Garred , Tina Hummelshoj Glue , Mikkel-Ole Skjodt
- Applicant: Omeros Corporation
- Applicant Address: US WA Seattle
- Assignee: Omeros Corporation
- Current Assignee: Omeros Corporation
- Current Assignee Address: US WA Seattle
- Agency: Womble Bond Dickinson (US) LLP
- Priority: EP 155621 2010.03.05
- The original application number of the division: US13582814
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K38/00 ; A61K45/06 ; C07K14/47 ; C07K14/705 ; C07K14/81
Abstract:
The present invention relates to novel chimeric molecules of ficolin-associated polypeptides, such as fusion polypeptides for the use in the treatment of conditions associated with inflammation, apoptosis, autoimmunity, coagulation, thrombotic or coagulopathic related diseases. The present invention further relates to nucleic acid molecules encoding such fusion polypeptides, vectors and host cells used in the production of the fusion polypeptides.
Public/Granted literature
- US20230295252A1 CHIMERIC INHIBITOR MOLECULES OF COMPLEMENT ACTIVATION Public/Granted day:2023-09-21
Information query
IPC分类:
